The Co-Chairmen of NTA, Professors Stephen Davis and Geoffrey Donnan, recently announced the receipt of an unrestricted grant from Boehringer Ingelheim. This funding will assist NTA to play an increasingly important role in the promotion of Australasian clinical research capabilities and the facilitation of interactions between study sponsors and clinicians across the neurosciences.